INS and Alzheimer disease: Over the 3-week course, it was reported that treatment with intranasal insulin (40 IU; 2 doses daily) significantly enhanced verbal and visuospatial working memory but not daily functioning or executive functioning in individuals with AD or MCI [92, 103].